Arcoma AB

Stockholm Stock Exchange ARCOMA.ST

Arcoma AB Market Capitalization on January 14, 2025: USD 12.81 M

Arcoma AB Market Capitalization is USD 12.81 M on January 14, 2025, a 18.52% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Arcoma AB 52-week high Market Capitalization is USD 22.50 M on June 25, 2024, which is 75.70% above the current Market Capitalization.
Arcoma AB 52-week low Market Capitalization is USD 9.83 M on January 23, 2024, which is -23.21% below the current Market Capitalization.
Arcoma AB average Market Capitalization for the last 52 weeks is USD 16.51 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: ARCOMA.ST

Arcoma AB

CEO	Mr. Mattias Leire
IPO Date	Nov. 14, 2014
Location	Sweden
Headquarters	AnnavAegen 1
Employees	32
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.

Key trends

Past 5 years